Valneva (VALN) Stock: Buy, Sell, or Hold?
VALN - Valneva SE American Depositary Shares
$6.66
-0.03 (-0.45%)
âŧ
5d:
-5.67%
30d:
+20.0%
90d:
+25.9%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When VALN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: VALN is fairly priced but lacks strong directional signals. At -1.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: VALN is fairly priced but lacks strong directional signals. At -1.0% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.67
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$6.00
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: VALN is currently trading at $6.66, which is considered fair relative to its 30-day fair value range of $5.78 to $7.07. The stock's valuation (Forward PE: 5.6) is in line with its historical norms (5.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, VALN is in a uptrend. Immediate support is located at $6.29, while resistance sits at $7.19.
Market Sentiment: VALN scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.25 (+83.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VALN is in a uptrend. Immediate support is located at $6.29, while resistance sits at $7.19.
Market Sentiment: VALN scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.25 (+83.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.78 -
$7.07
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (33/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 83.9% below Wall St target ($12.25)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.78 -
$7.07
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$6.29
Resistance Level
$7.19
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.60
Wall Street Target
$12.25
(+83.9%)
Revenue Growth (YoY)
-27.7%
Profit Margin
-110.3%
Valuation Discount vs History
-1.0% cheaper
PE vs Historical
5.6 vs 5.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.0%
(market-implied from PE analysis)
1-Year Target
$6.59
(-1%)
2-Year Target
$6.53
(-2%)
3-Year Target
$6.46
(-3%)
3-Yr Target (if PE normalizes)
(PE: 6â6)
$6.70
(+1%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.6 to 5.8
Stabilization Target:
$6.90
(+3.6%)
PE Expansion Potential:
+3.6%
Share & Embed Analysis
Last updated: September 13, 2026 3:26 AM ET
Data refreshes hourly during market hours. Next update: 4:26 AM
Data refreshes hourly during market hours. Next update: 4:26 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VALN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 52 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 49 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 41 HOLD |
